Cloud Factory (02512): Zheng Qi, Xu Ronghua, and Zhou Qianqian have been appointed as independent non-executive directors.
Cloud Factory (02512) announced that Mr. Ye Manlin has resigned as an independent non-executive director, a member of the company's audit committee, and a member of the company's remuneration committee, effective from January 2, 2026;
Mr. Cui Qi has resigned as an independent non-executive director, the chairman of the remuneration committee, a member of the audit committee, and a member of the company's nomination committee (together with the audit committee and the remuneration committee referred to as the "Board of Directors Committee"), effective from January 2, 2026;
Ms. Zhao Hong has resigned as an independent non-executive director, the chairman of the audit committee, and a member of the nomination committee, effective from January 2, 2026.
Cloud Factory (02512) announces that Mr. Ye Manlin has resigned as an independent non-executive director, a member of the Company's Audit Committee, and a member of the Company's Remuneration Committee, effective from January 2, 2026; Mr. Cui Qi has resigned as an independent non-executive director, the Chairman of the Remuneration Committee, a member of the Audit Committee, and a member of the Company's Nomination Committee (together with the Audit Committee and the Remuneration Committee referred to as the "Board Committee"), effective from January 2, 2026; Ms. Zhao Hong has resigned as an independent non-executive director, the Chairman of the Audit Committee, and a member of the Nomination Committee, effective from January 2, 2026.
Mr. Zheng Qi has been appointed as an independent non-executive director, the Chairman of the Remuneration Committee, a member of the Audit Committee, and a member of the Nomination Committee, effective from January 2, 2026; Ms. Xu Ronghua has been appointed as an independent non-executive director, the Chairman of the Audit Committee, and a member of the Nomination Committee, effective from January 2, 2026; and Ms. Zhou Qianqian has been appointed as an independent non-executive director, a member of the Audit Committee, and a member of the Remuneration Committee, effective from January 2, 2026.
Related Articles

CSPC PHARMA (01093): Nintedanib Ethanesulfonate Inhalation Powder Aerosol Approved for Clinical Trials in China.

"A+H" stock craze continues! In December, a total of 27 A-share listed companies are planning to go public in Hong Kong, with CPO leader Suzhou TFC Optical Communication among them.

REDCO HEALTHY (02370): There is currently no information available on how the pledged shares will be handled in the event of the forced execution by the administrator.
CSPC PHARMA (01093): Nintedanib Ethanesulfonate Inhalation Powder Aerosol Approved for Clinical Trials in China.

"A+H" stock craze continues! In December, a total of 27 A-share listed companies are planning to go public in Hong Kong, with CPO leader Suzhou TFC Optical Communication among them.

REDCO HEALTHY (02370): There is currently no information available on how the pledged shares will be handled in the event of the forced execution by the administrator.






